FR2726470B1 - Composition a base d'interferon - Google Patents

Composition a base d'interferon

Info

Publication number
FR2726470B1
FR2726470B1 FR9512845A FR9512845A FR2726470B1 FR 2726470 B1 FR2726470 B1 FR 2726470B1 FR 9512845 A FR9512845 A FR 9512845A FR 9512845 A FR9512845 A FR 9512845A FR 2726470 B1 FR2726470 B1 FR 2726470B1
Authority
FR
France
Prior art keywords
interferon
based composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9512845A
Other languages
English (en)
Other versions
FR2726470A1 (fr
Inventor
Charanjit Rai Behl
Aruna Sudhir Railkar
Navnit Hargovindas Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2726470A1 publication Critical patent/FR2726470A1/fr
Application granted granted Critical
Publication of FR2726470B1 publication Critical patent/FR2726470B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR9512845A 1994-11-03 1995-10-31 Composition a base d'interferon Expired - Fee Related FR2726470B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33370294A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
FR2726470A1 FR2726470A1 (fr) 1996-05-10
FR2726470B1 true FR2726470B1 (fr) 1999-02-26

Family

ID=23303915

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9512845A Expired - Fee Related FR2726470B1 (fr) 1994-11-03 1995-10-31 Composition a base d'interferon

Country Status (4)

Country Link
JP (1) JPH08208510A (fr)
DE (1) DE19540669A1 (fr)
FR (1) FR2726470B1 (fr)
IT (1) IT1275802B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
SK12772003A3 (sk) 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
DK1592416T3 (da) 2003-02-07 2009-04-20 Prometic Biosciences Inc Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
NL9101176A (nl) * 1991-07-05 1993-02-01 Stork Brabant Bv Zeefdrukinrichting met continue rapportering van roterende sjablonen.
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
JP3418423B2 (ja) * 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物

Also Published As

Publication number Publication date
IT1275802B1 (it) 1997-10-17
ITMI952202A0 (fr) 1995-10-25
JPH08208510A (ja) 1996-08-13
ITMI952202A1 (it) 1997-04-25
DE19540669A1 (de) 1996-05-09
FR2726470A1 (fr) 1996-05-10

Similar Documents

Publication Publication Date Title
FR2669537B1 (fr) Composition amincissante a base d'alpha-2-bloqueurs.
DK0736303T3 (da) Interferonopløsning
DE69434323D1 (de) Preparation d'un aimant permanent
DK0809996T3 (da) Interferonkonjugater
NO20002691D0 (no) IFNAR 2/IFN kompleks
BR9002396A (pt) Composicao estabilizada a base de 3-isotiazolonas
FR2726470B1 (fr) Composition a base d'interferon
ITMI920466A1 (it) Composizioni polimeriche a base di copoliammidi
FR2744917B1 (fr) Composition therapeutique a base d'acetaminophene
FR2641751B1 (fr) Hydroptere a coussin d'air
KR950016991U (ko) 이 강종 연연주용 치구
FR2724251B3 (fr) Structure d'etiquetage
IT9021735A0 (it) Composizioni farmaceutiche a base di calcitonine
FR2747426B1 (fr) Agencement d'escabeau a plate-forme autostable
ES1022301Y (es) "paletizador"
ITRC920003V0 (it) Gfv 92
SE9400296D0 (sv) trafic - Person - T-bana 1 A
ITMI920364A0 (it) Composizioni farmaceutiche a base di calcitonine
UA680S (uk) Судно-службово-роз'їздне
UA27881C2 (uk) Мийно-дезінфекційний засіб "збруч-2"
ITCT940031A0 (it) "sbufi"
BR7401400U (pt) "Cool-fast
IT8934601V0 (it) "3 b d r "
FR2644335B3 (fr) Table d'emargement
ES1025902Y (es) "mocho friegasuelos"

Legal Events

Date Code Title Description
ST Notification of lapse